Skip to main content

Lalande Kevin M.

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Lalande Kevin M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

MTEM Molecular Templates, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 21, 2022 (view filing)Jun 13-158 daysLateLalande Kevin M.Director, 10% OwnerPPurchase+222.0K$0.8936+$198.4KNew position222.0K after3 lots

LUMO Lumos Pharma, Inc.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 10, 2021 (view filing)Sep 82 daysLalande Kevin M.DirectorPPurchase+10.0K$11.21+$112.1K+1.4%730.4K after
Sep 7, 2021 (view filing)Sep 2-75 daysLalande Kevin M.DirectorPPurchase+24.4K$11.22+$273.8K+3.5%720.4K after3 lots
Sep 1, 2021 (view filing)Aug 30-Sep 12 daysLalande Kevin M.DirectorPPurchase+19.2K$10.66+$204.8K+2.8%696.0K after3 lots
Aug 27, 2021 (view filing)Aug 25-272 daysLalande Kevin M.DirectorPPurchase+26.1K$10.04+$261.8K+4.0%677.8K after3 lots
Aug 24, 2021 (view filing)Aug 20-244 daysLalande Kevin M.DirectorPPurchase+84.3K$9.20+$775.4K+14.8%651.8K after3 lots
Aug 19, 2021 (view filing)Aug 17-192 daysLalande Kevin M.DirectorPPurchase+64.9K$8.58+$556.6K+12.9%567.5K after3 lots
Aug 16, 2021 (view filing)Aug 12-164 daysLalande Kevin M.DirectorPPurchase+93.0K$7.79+$724.5K+22.7%502.6K after3 lots